Valneva SE (VALN) Cash & Current Investments (2019 - 2026)

Valneva SE (VALN) posted quarterly Cash & Current Investments of $119.8 million for Q1 2026, down 31.19% year-on-year from $174.1 million in Q1 2025, and down 4.0% on a QoQ basis from $124.8 million in Q4 2025.

Valneva SE (VALN) Cash & Current Investments (2019 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Cash & Current Investments for 8 consecutive years, with $119.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash & Current Investments fell 31.19% year-over-year to $119.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119.8 million (down 31.19% YoY) and the FY2025 annual result came in at $124.8 million, down 35.32% from the prior year.
  • Cash & Current Investments eased to $119.8 million in Q1 2026 per VALN's latest filing, from $124.8 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for VALN reached as high as $382.6 million in Q2 2022 and fell as low as $119.8 million in Q1 2026.
  • A 5-year average of $218.2 million and a median of $192.9 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 716230.0% — and 2023, when it slumped 55.61%.
  • Year by year, Cash & Current Investments stood at $326.1 million in 2022, then sank by 55.61% to $144.7 million in 2023, then soared by 33.29% to $192.9 million in 2024, then sank by 35.32% to $124.8 million in 2025, then dropped by 4.0% to $119.8 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $119.8 million, $124.8 million, and $163.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - 283.54 Mn
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - 61.40 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 472.89 Bn 468.10 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.12 Bn 114.87 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.90 Bn 50.72 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn 3.01 Bn
10 Valneva SE 839.18 Mn 719.39 Mn 5.38 Mn 119.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 119.79 Mn
Dec 31, 2025 124.78 Mn
Sep 30, 2025 163.25 Mn
Jun 30, 2025 185.05 Mn
Mar 31, 2025 174.10 Mn
Dec 31, 2024 192.91 Mn
Sep 30, 2024 177.90 Mn
Jun 30, 2024 149.54 Mn
Mar 31, 2024 201.01 Mn
Dec 31, 2023 144.74 Mn
Sep 30, 2023 194.88 Mn
Jun 30, 2023 232.61 Mn
Mar 31, 2023 289.59 Mn
Dec 31, 2022 326.06 Mn
Sep 30, 2022 297.05 Mn
Jun 30, 2022 382.61 Mn
Mar 31, 2022 354.20 Mn
Dec 31, 2021 45,518.17
Sep 30, 2021 282.15 Mn
Jun 30, 2021 375.30 Mn